sky rx semaglutide WEIGHT LOSS with GLP-1s WEIGHT LOSS with GLP-1s
Description
President Trump announced a deal with pharmaceutical companies Eli Lilly and Novo Nordisk to lower the cost of weight-loss drugs Wegovy and Zepbound
They sound like the latest and greatest the health
this adds medication specific consent pathways, optional addendum routing (compounded, telehealth, off label, pregnancy/coverage), provider counseling checklists, shared decision documentation, and a risk initials summary that makes key acknowledgements easy to verify
Most patients begin at lower doses and advance based on tolerance and clinical response over weeks, not days
Several papers on the subject have recently been published and BioSpace is taking a look at them.
Do GLP-1 marketing messages inspire purchases, or alienate consumers
